Small-vessel-diseases are a leading cause of Vascular Dementia. Our long-term goal is to elucidate the signaling pathways that control the structural and functional integrity of small arteries and understand the connections between these pathways and the development of small-vessel-diseases, as a prerequisite to the development of therapeutics. The research we propose is focused on the NotchS signaling pathway. Notch signaling is an evolutionary conserved pathway that plays a central role in the development and maturation of most vertebrate organs. We identified NotchS as the causative gene of CADASIL, an increasingly recognized autosomal dominant form of systemic small-vessel-disease causing stroke and dementia. We previously showed that 1?) CADASIL patients carry highly stereotyped missense mutations leading to an odd number of cysteine residues within the extracellular domain of NotchS; 2?) NotchS expression is largely confined to small arteries and vascular Smooth Muscle Cells (vSMC) and 3?) Mice expressing an archetypal CADASIL mutation (R90C) targeted in vSMC develop features of the CADASIL arteriopathy. Our specific hypothesis is that appropriate level of NotchS activity is critical for structural and functional integrity of small arteries by modulating an RBP-JK dependent, Hes/HEY independent pathway. That hypothesis is supported by our recent findings: 1 ?) In adult NotchS null mice, small arteries exhibit structural defects and cerebrovascular reactivity is strongly defective. Notably, NotchS null and CADASIL phenotypes are very different; 2?) RBP-JK dependent activity is abolished in arteries of NotchS null mice but expression level of Hes/HEY genes is unaffected. Here we propose three specific aims to further our understanding of NotchS- dependent small-vessel-diseases and NotchS signaling and address a major unresolved issue: the extent to which CADASIL mutations impair NotchS activity. We will construct and analyze NotchS gain-of-function mutant mice to determine effect of increasing NotchS activity in small arteries (Aim #1). We will determine the gene expression signature of loss and gain-of-function alleles of NotchS and identify direct target genes of NotchS by microarray analysis on isolated small arteries (Aim # 2). We will investigate effect of the archetypal R90C CADASIL mutation on NotchS wildtype activity in vivo using our Notch3R90C mice, NotchS null mice as a """"""""rescue"""""""" system and transgenic RBP-JK reporter mice (Aim # 3).

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS054122-03
Application #
7350196
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Refolo, Lorenzo
Project Start
2006-02-01
Project End
2010-01-31
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
3
Fiscal Year
2008
Total Cost
$165,168
Indirect Cost
Name
Nat'L Institute of Health/Med Research Inserm-Paris
Department
Type
DUNS #
381614494
City
Paris
State
Country
France
Zip Code
75013
Fouillade, Charles; Baron-Menguy, Céline; Domenga-Denier, Valérie et al. (2013) Transcriptome analysis for Notch3 target genes identifies Grip2 as a novel regulator of myogenic response in the cerebrovasculature. Arterioscler Thromb Vasc Biol 33:76-86
Monet-Leprêtre, Marie; Haddad, Iman; Baron-Menguy, Céline et al. (2013) Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. Brain 136:1830-45
Eikermann-Haerter, Katharina; Yuzawa, Izumi; Dilekoz, Ergin et al. (2011) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol 69:413-8
Joutel, Anne (2011) Pathogenesis of CADASIL: transgenic and knock-out mice to probe function and dysfunction of the mutated gene, Notch3, in the cerebrovasculature. Bioessays 33:73-80
Joutel, Anne; Monet-Leprêtre, Marie; Gosele, Claudia et al. (2010) Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 120:433-45
Tikka, Saara; Mykkänen, Kati; Ruchoux, Marie-Magdeleine et al. (2009) Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 132:933-9
Monet-Leprêtre, Marie; Bardot, Boris; Lemaire, Barbara et al. (2009) Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain 132:1601-12
Belin de Chantemele, E J; Retailleau, K; Pinaud, F et al. (2008) Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteries. Arterioscler Thromb Vasc Biol 28:2216-24
Fouillade, Charles; Chabriat, Hugues; Riant, Florence et al. (2008) Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain. Hum Mutat 29:452
Monet, Marie; Domenga, Valerie; Lemaire, Barbara et al. (2007) The archetypal R90C CADASIL-NOTCH3 mutation retains NOTCH3 function in vivo. Hum Mol Genet 16:982-92